Advancing Parkinson’s Disease Research
The Role of Blood-Based Biomarkers
App Note
Parkinson’s disease (PD) is the second most common neurodegenerative disorder, yet early and accurate diagnosis remains a challenge. Blood-based biomarkers offer a minimally invasive solution to detect and monitor PD, paving the way for improved patient outcomes and accelerated drug development. Read this app note to see how the latest advancements in biomarker detection can transform Parkinson’s disease research and clinical care.
Fill out the form to download the App Note